Evidence map›Paper›PMID 33788100›Full record

ArticleBulletin of experimental biology and medicine2021

SkQR1 Reduces Neurologic Deficit Caused by Rat Brain Compression Ischemia.

E E Genrikhs, E V Stelmashook, P D Rogozin, S V Novikova, O P Aleksandrova, V B Sobolev, V G Skrebitsky, N K Isaev

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

E E GenrikhsResearch Center of Neurology, Moscow, Russia.
E V StelmashookResearch Center of Neurology, Moscow, Russia.
P D RogozinResearch Center of Neurology, Moscow, Russia.
S V NovikovaResearch Center of Neurology, Moscow, Russia.
O P AleksandrovaResearch Center of Neurology, Moscow, Russia.
V B SobolevResearch Center of Neurology, Moscow, Russia.
V G SkrebitskyResearch Center of Neurology, Moscow, Russia.
N K IsaevResearch Center of Neurology, Moscow, Russia. nisaev61@mail.ru.
Research Center of Neurology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective effect of antioxidant SkQR1 was examined on the model of left-sided compression ischemia in rat sensorimotor cortex. The special tests aimed to determine the neurologic deficit in the limbs and assess performance of the forelimbs showed that a 2.5-min ischemia produced no disturbance in the limb functions on postsurgery days 1, 3, and 7. Elevation of compression time resulted in neurologic deficit in animals, and its severity depended on this time. A single intravenous injection of SkQR1 (250 nmol/kg body weight) performed 30 min after ischemia significantly reduced the degree of neurologic deficit. In vitro model of ischemia in surviving rat hippocampal slices showed that a 15-min-long ischemia significantly inhibited the population excitatory postsynaptic potentials, which did not restore during reperfusion. Preincubation of the slices with SkQR1 did not significantly affect recovery of these potentials.

Indexed as

AnimalsAntioxidantsBrain IschemiaExcitatory Postsynaptic PotentialsHippocampusMaleMitochondriaNeuroprotective AgentsPlastoquinoneRatsRhodamines10-(6'-plastoquinonyl) decylrhodamine 19AntioxidantsNeuroprotective AgentsPlastoquinoneRhodaminesacute hippocampal slicescompression ischemiamitochondrial-targeted antioxidantsneuronspopulation excitatory postsynaptic potentials (pEPSP)

Identifiers

PMID33788100
OpenAlexW3144429596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.